LFCR vs STE · $207.1M cap vs P/E 25, rev $5.46B
Lifecore Biomedical Inc. (LFCR) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
LFCR does not have a complete income-statement cache yet.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
LFCR currently screens at market cap $207.1M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the LFCR and STE stock pages for the full models.
Not investment advice.